| 000 | 01526 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513041708.0 | ||
| 264 | 0 | _c19950530 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0009-9147 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWevers, R A | |
| 245 | 0 | 0 |
_aStandardized method for high-resolution 1H-NMR of cerebrospinal fluid. _h[electronic resource] |
| 260 |
_bClinical chemistry _cMay 1995 |
||
| 300 |
_a744-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmino Acids _xcerebrospinal fluid |
| 650 | 0 | 4 |
_aCanavan Disease _xcerebrospinal fluid |
| 650 | 0 | 4 | _aCarbon-Carbon Ligases |
| 650 | 0 | 4 |
_aCerebrospinal Fluid _xchemistry |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGas Chromatography-Mass Spectrometry |
| 650 | 0 | 4 |
_aHistidine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aLactates _xcerebrospinal fluid |
| 650 | 0 | 4 | _aLactic Acid |
| 650 | 0 | 4 |
_aLigases _xdeficiency |
| 650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolism, Inborn Errors _xcerebrospinal fluid |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aValerates _xcerebrospinal fluid |
| 650 | 0 | 4 | _aVolatilization |
| 700 | 1 | _aEngelke, U | |
| 700 | 1 | _aWendel, U | |
| 700 | 1 | _ade Jong, J G | |
| 700 | 1 | _aGabreëls, F J | |
| 700 | 1 | _aHeerschap, A | |
| 773 | 0 |
_tClinical chemistry _gvol. 41 _gno. 5 _gp. 744-51 |
|
| 999 |
_c7728423 _d7728423 |
||